Myocardial infarction in the diabetic patient
Related Experiment Videos
Insights
Diabetic patients face higher mortality from myocardial infarction, with poorer long-term survival compared to non-diabetics. Beta-blocker therapy may offer some survival benefits for these individuals.
Area of Science:
- Cardiology
- Endocrinology
- Diabetology
Background:
- Coronary events in diabetic patients may present differently than in non-diabetic individuals.
- Existing data suggest potential disparities in symptomatology and prognosis.
Purpose of the Study:
- To review recent data on the differences in coronary events between diabetic and non-diabetic patients.
- To examine the acute and long-term outcomes of myocardial infarction in diabetic individuals.
Main Methods:
- Review of recent data and literature.
- Analysis of mortality rates during the acute phase of myocardial infarction.
- Assessment of follow-up survival rates.
Main Results:
- Diabetic patients exhibit higher mortality during the acute phase of myocardial infarction.
- Congestive heart failure and cardiogenic shock are more frequent in diabetic patients.
- Diabetic survivors of myocardial infarction have lower long-term survival rates than non-diabetic survivors.
Conclusions:
- Diabetic patients experience worse outcomes following myocardial infarction compared to non-diabetic individuals.
- Beta-adrenergic-blocker therapy shows potential for improving survival in diabetic patients post-myocardial infarction.
Abstract:
It has long been thought that the symptomatology and prognosis of coronary events in patients with diabetes may differ from those in nondiabetic persons. A review of recent data demonstrates a higher mortality during the acute phase of myocardial infarction for diabetic patients than for their nondiabetic counterparts, possibly related to a higher incidence of congestive heart failure and cardiogenic shock. The clinical course of diabetic patients with infarction and the role of insulin in myocardial adaptation to ischemia are both reviewed. Diabetic patients surviving the acute phase of myocardial infarction have a lower survival in follow-up than nondiabetic survivors, although some improvement in survival has been noted following beta-adrenergic-blocker therapy.